GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $1.87 million. The enterprise value is -$2.74 million.

Market Cap	1.87M
Enterprise Value	-2.74M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 2.93 million shares outstanding. The number of shares has increased by 4,890.31% in one year.

Current Share Class	2.93M
Shares Outstanding	2.93M
Shares Change (YoY)	+4,890.31%
Shares Change (QoQ)	+590.51%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	4.71%
Float	2.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.88
P/TBV Ratio	0.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.04.

Current Ratio	3.10
Quick Ratio	2.77
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.87

Financial Efficiency

Return on equity (ROE) is -280.72% and return on invested capital (ROIC) is -166.58%.

Return on Equity (ROE)	-280.72%
Return on Assets (ROA)	-102.11%
Return on Capital (ROIC)	-166.58%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-99.35%
50-Day Moving Average	0.63
200-Day Moving Average	4.07
Relative Strength Index (RSI)	43.74
Average Volume (20 Days)	3,590,837

Short Selling Information

The latest short interest is 924,631, so 31.58% of the outstanding shares have been sold short.

Short Interest	924,631
Short Previous Month	225,823
Short % of Shares Out	31.58%
Short % of Float	31.69%
Short Ratio (days to cover)	0.10

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.06M
Pretax Income	-12.77M
Net Income	-8.26M
EBITDA	-8.05M
EBIT	-8.06M
Earnings Per Share (EPS)	-$7.90

Full Income Statement

Balance Sheet

The company has $4.75 million in cash and $131,000 in debt, giving a net cash position of $4.62 million or $1.58 per share.

Cash & Cash Equivalents	4.75M
Total Debt	131,000
Net Cash	4.62M
Net Cash Per Share	$1.58
Equity (Book Value)	3.66M
Book Value Per Share	0.73
Working Capital	3.61M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-12.17M
Capital Expenditures	n/a
Free Cash Flow	-12.17M
FCF Per Share	-$4.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,890.31%
Shareholder Yield	-4,890.31%
Earnings Yield	-441.68%
FCF Yield	-650.63%

Analyst Forecast

The average price target for GRI Bio is $12.00, which is 1,777.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	1,777.93%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 18, 2024. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Jun 18, 2024
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1